🔍 Pharmidex In Silico Drug Discovery – Step 3: Determination of Active/Binding Sites! 🎯💻
February 25, 2025

At Pharmidex, we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success.


✨ Why is this step crucial?

✅ Accurate identification of binding pockets for targeted drug interactions

✅ AI-powered pocket detection and molecular dynamics simulations

✅ Enhanced precision in hit identification and lead optimization

✅ Seamless integration with our next in silico pipeline steps


By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline!


📽️ Watch our latest video (2/5) to explore how we map active sites with precision!


📩 Let’s collaborate to revolutionize drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

Congratulate Ash Alavijeh as Chief Operating Officer

May 7, 2026
We are delighted to announce and congratulate Ash Alavijeh on his appointment as Chief Operating Officer at Pharmidex . Ash has been an integral part of Pharmidex’s journey, bringing strong leadership, strategic vision and a deep commitment to advancing our capabilities in drug discovery and development. In his new role as COO, he will play a key part in driving operational excellence and supporting the continued growth of the company. This appointment reflects both Ash’s contributions to date and our confidence in his leadership as we continue to expand and evolve. Please join us in congratulating Ash on this well-deserved achievement.

World Asthma Day 🌍

May 5, 2026
Asthma affects over 260 million people worldwide and remains a significant unmet medical need. At Pharmidex , we are proud to support the development of next-generation respiratory therapies through: In vivo respiratory disease models Whole Body Plethysmography (WBP) for functional readouts Integrated PK/PD and bioanalysis Our focus is simple: generate high-quality data that enables confident decision-making and accelerates progress for patients. Because behind every dataset is a patient waiting to breathe easier.

Funding Opportunity for Early-Stage Innovators in Scotland

May 1, 2026
Early-stage innovators based in Scotland have access to a significant opportunity to advance their programs toward ProofOfConcept, with an additional £2.85M fund from the Scottish Government aimed at supporting early development and enabling further investment. 🗓️ Deadline: 8th May At Pharmidex , we work alongside our partners to generate robust, translational data that supports confident decision-making across early discovery and preclinical development. Our capabilities include: TargetExpression ModeOfActionStudies TargetEngagement HitIdentification ADME and PK profiling If you are preparing an application and require scientific input or timely quotations, we would be pleased to support your programme. 🔗 https://lnkd.in/eZ6vVjgN
More Posts